Extent of resection and outcome after curative resection for intrahepatic cholangiocarcinoma

Surgical Oncology Clinics of North America

Volumn 11, Issue 4, 2002, Pages 969-983

  Kokudo, Norihiro ^a   Makuuchi, Masatoshi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOXORUBICIN; FLUOROURACIL; MITOMYCIN C;

BILE DUCT CARCINOMA; CANCER ADJUVANT THERAPY; CANCER CLASSIFICATION; CANCER SURVIVAL; HUMAN; LIVER RESECTION; LIVER TRANSPLANTATION; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PREOPERATIVE PERIOD; PROGNOSIS; REVIEW;

ANIMALS; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHEMOTHERAPY, ADJUVANT; CHOLANGIOCARCINOMA; HUMANS; LIVER TRANSPLANTATION; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; NEOPLASM INVASIVENESS; PROGNOSIS; RADIOTHERAPY, ADJUVANT; TREATMENT OUTCOME;

EID: 0036813568     PISSN: 10553207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1055-3207(02)00040-6     Document Type: Review

References (48)

1. Groen PC, Gores GJ, LaRusso NF, Gunderson LL, Nagorney DM. Biliary tract cancers. N Engl J Med 1999;341:1368-78.
2. Nakeeb A, Pitt HA, Sohn TA, Coleman J, Abrams RA, Piantadosi S, et al. Cholangiocarcinoma: A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg 1996;224:463-75.
3. The Liver Cancer Study Group of Japan. The Primary liver cancer in Japan-sixth report. Cancer 1987;60:1400-11.
4. Cherqui D, Tantawi B, Alon R, Piedbois P, Rahmouni A, Dhumeaux D, et al. Intrahepatic cholangiocarcinoma: Results of aggressive surgical treatment. Arch Surg 1995;130:1073-8.
5. Patel T. Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology 2001;33:1353-7.
6. Chen M-F, Jan Y-Y, Wang C-S, Jeng L-B, Hwang T-L. Clinical experience in 20 hepatic resections for peripheral cholangiocarcinoma. Cancer 1989;64:2226-32.
7. Kawarada Y, Mizumoto R. Cholangiocellular carcinoma of the liver. Am J Surg 1984;147:354-9.
8. Taylor-Robinson SD, Foster GR, Arora S, Hargreaves S, Thomas HC. Increase in primary liver cancer in the UK, 1979-94. Lancet 1997;350:1142-3.
9. Sorensen HT, Friis S, Olsen JH, Thulstrup AM, Mellemkjaer L, Linet M, et al. Risk of liver and other types of cancer in patients with cirrhosis: A nationwide cohort study in Denmark. Hepatology 1998;28:921-5.
10. Belamaric J. Intrahepatic bile duct carcinoma and C sinensis in Hong Kong. Cancer 1982;31:468-73.
11. Chen PH, Lo HW, Wang CL, et al. Cholangiocellular carcinoma in hepatolithiasis. J Clin Gastroenterol 1984;6:539-47.
12. Rosen CB, Nagorney DM, Wiesner RH, Coffey RJ, La Russo NF. Cholangiocarcinoma complicating primary sclerosing cholangitis. Ann Surg 1991;213:21-5.
13. Inoue K, Makuuchi M, Takayama T, et al. Long-term survival and prognostic factors in the surgical treatment of mass-forming type cholangiocarcinoma. Surgery 2000;127:498-505.
14. Kobayashi M, Ikeda K, Saitoh S, Suzuki F, Tsubota A, Suzuki Y, et al. Incidence of primary cholangiocellular carcinoma of the liver in Japanese patients with hepatitis C virus-related cirrhosis. Cancer 2000;88:2471-7.
15. Sell S, Dunsford HA. Evidence for the stem cell origin of hepatocellular carcinoma and cholangiocarcinoma. Am J Pathol 1989;134:1347-63.
16. D'Errico A, Baccarini P, Fiorentino M, Ceccarelli C, Bonazzi C, Ponzetto A. Histogenesis of primary liver carcinomas: Strengths and weakness of cytokeratin profile and albumin mRNA detection. Hum Pathol 1996;27:599-604.
17. Sasaki A, Aramaki M, Kawano K, Morii Y, Nakashima K, Yoshida T, et al. Intrahepatic peripheral cholangiocarcinoma: Mode of spread and choice of surgical treatment. Br J Surg 1998;85:1206-9.
18. Yamanaka N, Okamoto E, Ando T, Oriyama T, Fujimoto J, Furukawa K, et al. Clinicopathologic spectrum of resected extraductal mass-forming intrahepatic cholangiocarcinoma. Cancer 1995;76:2449-56.
19. Liver Cancer Study Group of Japan. Classification of primary liver cancer. Tokyo: Kanehara; 1997. p. 21.
20. Sano T, Kamiya J, Nagino M, Uesaka K, Kondo S, Kanai M, et al. Macroscopic classification and preoperative diagnosis of intrahepatic cholangiocarcinoma in Japan. J Hepatobiliary Pancreat Surg 1999;6:101-7.
21. Craig JR, Peters RI, Edmondson HA. Tumors of the liver and intrahepatic bile ducts. In: Hartmann WH, editor. Atlas of Tumor Pathology. 2nd Series. Washington, DC: Armed Forces Institute of Pathology; 1989.
22. Roayaie S, Guarrera JV, Ye MQ, Thumg SN, Emre S, Fishbein TM, et al. Aggressive surgical treatment of intrahepatic cholangiocarcinoma: Predictors of outcomes. J Am Coll Surg 1998;187:365-72.
23. Madariaga JR, Iwatsuki S, Todo S, Lee RG, Irish W, Starzl TE. Liver resection for hilar and peripheral cholangiocarcinomas: A study of 62 cases. Ann Surg 1998;227:70-9.
24. Chu K-M, Lai ECS, Al-Hadeedi S, Arcilla CE, Lo C-M, Liu C-L, et al. Intrahepatic cholangiocarcinoma. World J Surg 1997;21:301-6.
25. Nakajima T, Kondo Y, Miyazaki M, Okui K. A histopathologic study of 102 cases of intrahepatic cholangiocarcinoma: Histologic classification and modes of spreading. Hum Pathol 1988;19:1228-34.
26. Weinbren K, Mutum SS. Pathological aspects of cholangiocarcinoma. J Pathol 1983;139:217-38.
27. Berdah SV, Delpero JR, Garcia S, Hardwigsen J, Le Treut YP. A western surgical experience of peripheral cholangiocarcinoma. Br J Surg 1996;83:1517-21.
28. Pichlmayr R, Lamesch P, Weimann A, Tusch G, Ringe B. Surgical treatment of cholangiocellular carcinoma. World J Surg 1995;19:83-8.
29. Jan Y-Y, Jeng L-B, Hwang T-L, Wang C-S, Chen M-F, Chen T-J. Factors influencing survival after hepatectomy for peripheral cholangiocarcinoma. Hepatogastroenterology 1996;43:614-9.
30. Chou F-F, Sheen-Chen S-M, Chen Y-S, Chen M-C, Chen C-L. Surgical treatment of cholangiocarcinoma. Hepatogastroenterology 1997;44:760-5.
31. Casavilla FA, Marsh JW, Iwatsuki S, Todo S, Lee RG, Madariaga JR, et al. Hepatic resection and transplantation for peripheral cholangiocarcinoma. J Am Coll Surg 1997;185:429-36.
32. Isaji S, Kawarada Y, Taoka H, Tabata M, Suzuki H, Yokoi H. Clinicopathological features and outcome of hepatic resection for intrahepatic cholangiocarcinoma in Japan. J Hepatobiliary Pancreat Surg 1999;6:108-16.
33. Valverde A, Bonhomme N, Farges O, Sauvanet A, Flejou JF, Belghiti J. Resection of intrahepatic cholangiocarcinoma: A Western experience. J Hepatobiliary Pancreat Surg 1999;6:122-7.
34. Kim H-J, Yun S-S, Jung K-H, Kwun W-H, Choi J-H. Intrahepatic cholangiocarcinoma in Korea. J Hepatobiliary Pancreat Surg 1999;6:142-8.
35. The Liver Cancer Study Group of Japan. The 14th Report of the Nationwide Survey of Primary Liver Cancer in Japan (1996-1997). Kyoto: The Liver Cancer Study Group of Japan; 2000.
36. Kawarada Y, Mizumoto R. Diagnosis and treatment of cholangiocellular carcinoma of the liver. Hepatogastroenterology 1990;37:176-81.
37. Makuuchi M, Thai BL, Takayasu K, et al. Preoperative portal embolizafion to increase safety of major hepatectomy for hilar bile duct carcinoma: A preliminary report. Surgery 1990;107:521-7.
38. Izumi R, Shimizu K, Kirihara M, Yagi M, Matsui O, Nonomura A, et al. Long-term survival of peripheral intrahepatic cholangiocarcinoma with distant metastasis. Am J Roentogenol 1995;90:505-7.
39. Yamamoto J, Kosuge T, Takayama T, Shimada K, Makuuchi M, Yoshida J. Surgical treatment of intrahepatic cholangiocarcinoma: Four patients surviving more than five years. Surgery 1992;111:617-22.
40. Goldstein RM, Stone M, Tillery W, Senzer N, Levy M, Husberg BS, et al. Is liver transplantation indicated for cholangiocarcinoma? Am J Surg 1993;166:768-72.
41. Oberfield RA, Rossi RL. The role of chemotherapy in the treatment of bile duct cancer. World J Surg 1988;12:105-8.
42. Okuda K, Kubo Y, Okazaki N, Arishima T, Hashimoto M, Jinnouchi S, et al. Clinical aspects of intrahepatic bile duct carcinoma including hilar carcinoma: A study of 57 autopsy-proven cases. Cancer 1977;39:232-46.
43. Ringe B, Wittekind C, Bechstein WO, Bunzendahl H, Pichlmayr R. The role of liver transplantation in hepatobiliary malignancy: A retrospective analysis of 95 patients with particular regard to tumor stage and recurrence. Ann Surg 1989;209:88-98.
44. Ismail T, Angrisani L, Gunson BK, et al. Primary hepatic malignancy: The role of liver transplantation. Br J Surg 1990;77:983-7.
45. Iwatsuki S, Gordon RD, Shaw BW, Starzl TE. Role of liver transplantation in cancer therapy. Ann Surg 1985;202:401-7.
46. Delcore R, Eisenach JB, Payne KM, Bhatia P, Forster J. Risk of occult carcinomas in patients undergoing orthotopic liver transplantation for end-stage liver disease secondary to primary sclerosing cholangitis. Transplant Proc 1993;25:1883-4.
47. Yokoyama I, Carr B, Saitsu H, Iwatsuki S, Starzl TE. Accelerated growth rates of recurrent hepatocellular carcinoma after liver transplantation. Cancer 1991;68:2095-100.
48. Yamamoto J, Kosuge T, Takayama T, Shimada K, Yamasaki S, Sakamoto M, et al. Intrahepatic cholangiocarcinoma presenting intrabile duct extension: Clinicopathologic study of five resected cases. Jpn J Clin Oncol 1997;27:18-21.